Cluster analysis of the Yale Global Tic Severity Scale (YGTSS): symptom dimensions and clinical correlates in an outpatient youth sample.
Tic disorders are heterogeneous, with symptoms varying widely both within and across patients. Exploration of symptom clusters may aid in the identification of symptom dimensions of empirical and treatment import. This article presents the results of two studies investigating tic symptom clusters using a sample of 99 youth (M age = 10.7, 81% male, 77% Caucasian) diagnosed with a primary tic disorder (Tourette's disorder or chronic tic disorder), across two university-based outpatient clinics specializing in tic and related disorders. In Study 1, a cluster analysis of the Yale Global Tic Severity Scale (YGTSS) identified four symptom dimensions: predominantly complex tics; simple head/face tics; simple body tics; and simple vocal/facial tics. In Study 2, these clusters were shown to be differentially associated with demographic and clinical characteristics. Findings lend support to prior research on tic phenomenology, help to organize treatment goals, and suggest symptom dimensions of tic disorders for further evaluation.
Kircanski
Katharina
K
Department of Psychology, University of California-Los Angeles, 1285 Franz Hall, Box 951563, Los Angeles, CA 90095-1563, USA. kkir@ucla.edu
Woods
Douglas W
DW
Chang
Susanna W
SW
Ricketts
Emily J
EJ
Piacentini
John C
JC
D000293:Adolescent; D002648:Child; D016000:Cluster Analysis; D005260:Female; D006801:Humans; D008297:Male; D010045:Outpatients; D012720:Severity of Illness Index; D013981:Tic Disorders / Q000175:diagnosis* / Q000503:physiopathology
Curr Treat Options Neurol. 2003 Jul;5(4):299-308
12791197
J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
9204677
Arch Gen Psychiatry. 1986 Dec;43(12):1180-2
3465280
Psychiatry Res. 2004 Nov 30;129(1):91-8
15572188
Dev Med Child Neurol. 2003 Oct;45(10):700-3
14515942
J Dev Behav Pediatr. 2005 Dec;26(6):397-403
16344654
Can J Physiol Pharmacol. 2004 Aug-Sep;82(8-9):732-9
15523530
Am J Hum Genet. 1999 Nov;65(5):1428-36
10521310
J Clin Child Adolesc Psychol. 2002 Sep;31(3):335-42
12149971
Aust N Z J Psychiatry. 2006 Jan;40(1):67-73
16403042
J Child Neurol. 2006 Aug;21(8):719-25
16970874
Psychiatr Genet. 2007 Jun;17(3):143-52
17417057
Mol Psychiatry. 2005 Jan;10(1):6-13
15618952
J Am Acad Child Adolesc Psychiatry. 2001 Aug;40(8):937-44
11501694
J Child Neurol. 2006 Aug;21(8):642-9
16970864
J Am Acad Child Adolesc Psychiatry. 1992 May;31(3):472-7
1592779
Science. 1996 Aug 30;273(5279):1225-7
8703056
Psychol Assess. 2000 Sep;12(3):287-97
11021152
Dev Med Child Neurol. 2000 Jul;42(7):436-47
10972415
Br J Psychiatry. 2008 Jul;193(1):31-6
18700215
Adolesc Med. 2002 Oct;13(3):537-51
12270799
Schizophr Bull. 1982;8(2):267-78
6955942
Brain Dev. 2005 Aug;27(5):349-52
16023550
Psychiatry Res. 2007 Jan 15;149(1-3):231-7
17150256
J Am Acad Child Adolesc Psychiatry. 1997 Jun;36(6):844-52
9183141
Psychol Assess. 2005 Dec;17(4):486-91
16393016
J Am Acad Child Adolesc Psychiatry. 2007 Aug;46(8):947-968
17667475
Biol Psychiatry. 2001 Oct 15;50(8):559-65
11690590
J Am Acad Child Adolesc Psychiatry. 1989 Jul;28(4):566-73
2768151
Am J Psychiatry. 2002 Feb;159(2):291-6
11823273
J Psychosom Res. 2008 Nov;65(5):487-96
18940379
Biol Psychiatry. 2007 Feb 1;61(3):292-300
16581034
Brain Dev. 2003 Dec;25 Suppl 1:S24-8
14980368
Am J Med Genet B Neuropsychiatr Genet. 2003 Aug 15;121B(1):105-11
12898584